Anti-diabetic effects of resveratrol
- PMID: 21261639
- DOI: 10.1111/j.1749-6632.2010.05844.x
Anti-diabetic effects of resveratrol
Abstract
Diabetes mellitus is a complex metabolic disease affecting about 5% of people all over the world. Data from the literature indicate that resveratrol is a compound exerting numerous beneficial effects in organisms. Rodent studies, for example, have demonstrated that resveratrol decreases blood glucose in animals with hyperglycemia. This effect seems to predominantly result from increased intracellular transport of glucose. Resveratrol was also demonstrated to induce effects that may contribute to the protection of β cells in diabetes. In experiments on pancreatic islets, the ability of resveratrol to reduce insulin secretion was demonstrated; this effect was confirmed in animals with hyperinsulinemia, in which resveratrol decreased blood insulin levels. Moreover, inhibition of cytokine action and attenuation of the oxidative damage of the pancreatic tissue by resveratrol were recently shown. Studies of animals with insulin resistance indicate that resveratrol may also improve insulin action. The mechanism through which resveratrol improves insulin action is complex and involves reduced adiposity, changes in gene expression, and changes in the activities of some enzymes. These data indicate that resveratrol may be useful in preventing and treating diabetes.
© 2011 New York Academy of Sciences.
Similar articles
-
Resveratrol and diabetes: from animal to human studies.Biochim Biophys Acta. 2015 Jun;1852(6):1145-54. doi: 10.1016/j.bbadis.2014.10.013. Epub 2014 Oct 27. Biochim Biophys Acta. 2015. PMID: 25445538 Review.
-
Protection of pancreatic beta-cells: is it feasible?Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. doi: 10.1016/j.numecd.2007.05.004. Nutr Metab Cardiovasc Dis. 2008. PMID: 18096375 Review.
-
Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats.J Cell Physiol. 2010 Aug;224(2):423-32. doi: 10.1002/jcp.22138. J Cell Physiol. 2010. PMID: 20333650
-
Resveratrol and diabetes: A critical review of clinical studies.Biomed Pharmacother. 2017 Nov;95:230-234. doi: 10.1016/j.biopha.2017.08.070. Epub 2017 Sep 12. Biomed Pharmacother. 2017. PMID: 28843911 Review.
-
Resveratrol, obesity and diabetes.Eur J Pharmacol. 2010 Jun 10;635(1-3):1-8. doi: 10.1016/j.ejphar.2010.02.054. Epub 2010 Mar 19. Eur J Pharmacol. 2010. PMID: 20303945 Review.
Cited by
-
Antidiabetic Potential of Medicinal Plants and Their Active Components.Biomolecules. 2019 Sep 30;9(10):551. doi: 10.3390/biom9100551. Biomolecules. 2019. PMID: 31575072 Free PMC article. Review.
-
Antidiabetic effects of novel cell culture established from grapevine, Vitis vinifera cv. Koshu.Cytotechnology. 2018 Jun;70(3):993-999. doi: 10.1007/s10616-018-0203-y. Epub 2018 Mar 15. Cytotechnology. 2018. PMID: 29546683 Free PMC article.
-
Resveratrol ameliorates mitochondrial dysfunction but increases the risk of hypoglycemia following hemorrhagic shock.J Trauma Acute Care Surg. 2014 Dec;77(6):926-33. doi: 10.1097/TA.0000000000000358. J Trauma Acute Care Surg. 2014. PMID: 25248062 Free PMC article.
-
Differential gene expression in liver tissues of streptozotocin-induced diabetic rats in response to resveratrol treatment.PLoS One. 2015 Apr 23;10(4):e0124968. doi: 10.1371/journal.pone.0124968. eCollection 2015. PLoS One. 2015. PMID: 25905778 Free PMC article.
-
Leucine signaling in the pathogenesis of type 2 diabetes and obesity.World J Diabetes. 2012 Mar 15;3(3):38-53. doi: 10.4239/wjd.v3.i3.38. World J Diabetes. 2012. PMID: 22442749 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
